Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2Phase 4 1Phase 2 1

Status

Completed 3Active not recruiting 2Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Venous Thromboembolism 1Stroke 1Skin Neoplasms 1Sarcoma 1Restless Legs Syndrome 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Parkinson Disease 1Odontogenic Cysts 1Multiple Sclerosis 1Migraine Disorders 1Localized Advanced Rectal Adenocarcinoma 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Hematoma 1Esophageal Neoplasms 1Epilepsy 1Dysbiosis 1Crohn Disease 1Colitis, Ulcerative 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Concussion 1Bone Neoplasms 1

Interventions

Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Enrolling by invitation × Sarcoma × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡